These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4740230)

  • 21. Elimination of N-(2-aminoacyl)-2,6-xylidines after intravenous infusion in dogs.
    Berlin-Wahlén A; Barkus JC; Keenaghan JB; Lebeaux M; Tenthorey PA
    Acta Pharm Suec; 1977; 14(5-6):417-24. PubMed ID: 596160
    [No Abstract]   [Full Text] [Related]  

  • 22. Metabolic pathways of aprindine.
    Murphy PJ
    Acta Cardiol; 1974; Suppl 18():131-42. PubMed ID: 4213697
    [No Abstract]   [Full Text] [Related]  

  • 23. [Electrophysiologic effects of anti-arrhythmia agents. Their predictive value of therapeutic effects].
    Lévy S
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():29-35. PubMed ID: 6803700
    [No Abstract]   [Full Text] [Related]  

  • 24. Chronic administration of aprindine during maintenance hemodialysis.
    Takata Y; Tsuchihashi T; Nakamura S; Hirota Y
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):553-6. PubMed ID: 9455712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Anti-arrhythmic properties of specific bradycardic agents from the group of 2-mercaptobenzimidazole derivatives].
    Chichkanov GG; Tsorin IB; Kirsanova GIu; Berdiaev SIu; Turilova AI
    Eksp Klin Farmakol; 1997; 60(5):35-9. PubMed ID: 9483403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A comparative study of the antiarrhythmic action of bonnecor and the mesidide derivatives of alpha-azacycloalkane carboxylic acids].
    Paliani-Katsitadze NSh; Berdiaev SIu; Turilova AI; Kaverina NV; Likhosherstov AM
    Eksp Klin Farmakol; 1994; 57(3):15-7. PubMed ID: 8049618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical pharmacologic studies on 1-nitro-9-(dimethylamino)-acridine and 1-nitro-10-(dimethylaminoethyl)-9-acridone. I. Acute and subacute action.
    Pelczarska A; Kowalczyk-Bronisz SH; Blaszczyk B; Gieldanowski J; Patkowski J
    Arch Immunol Ther Exp (Warsz); 1974; 22(6):823-42. PubMed ID: 4451445
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pharmacology of N-propyl-ajmaline bromide (NPAB)].
    Gendenshteĭn EI
    Farmakol Toksikol; 1970; 33(3):303-5. PubMed ID: 5453025
    [No Abstract]   [Full Text] [Related]  

  • 29. Toxicological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 1. Subacute and chronic toxicity in rats and dogs.
    Gaetani M; Debeus R; Bonardi G; Coppi G
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:216+. PubMed ID: 5067196
    [No Abstract]   [Full Text] [Related]  

  • 30. Atrial fibrillation: rate versus rhythm control.
    Amani F; Smith ES
    J Ark Med Soc; 2005 Oct; 102(4):110-2. PubMed ID: 16265929
    [No Abstract]   [Full Text] [Related]  

  • 31. The mammalian toxicity of dicyclopentadiene.
    Kinkead ER; Pozzani UC; Geary DL; Carpenter CP
    Toxicol Appl Pharmacol; 1971 Dec; 20(4):552-61. PubMed ID: 5169072
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antazolin(Antistina) in treatment of supraventricular tachycardia].
    Mortensen E; Andersen M
    Ugeskr Laeger; 1974 Jun; 136(25):1393-4. PubMed ID: 4841115
    [No Abstract]   [Full Text] [Related]  

  • 33. The chronic toxicity of the preparation M-71 (Craviten).
    Mach Z; Swierczak J; Pawlik T; Wajdowicz A; Barycz M
    Pol J Pharmacol Pharm; 1980; 32(6):889-91. PubMed ID: 7243685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of intravenous aprindine on cardiac performance in patients with various degrees of myocardial damage].
    Santinelli V; Chiariello M; Ferro G; Tari MG; Condorelli M
    Boll Soc Ital Cardiol; 1978; 23(6):1015-20. PubMed ID: 261867
    [No Abstract]   [Full Text] [Related]  

  • 35. Combination antiarrhythmic therapy: 1 + 1 > 2?
    Tang L
    J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1098-100. PubMed ID: 18554208
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cardiovascular activity of triethylamine nitrosopentacyanoferrate].
    Pham-Huu-Chanh ; Lecointe P; Kan P; Patte J
    Agressologie; 1973; 14(2):111-9. PubMed ID: 4776372
    [No Abstract]   [Full Text] [Related]  

  • 37. Aprindine in the treatment of the idiopathic QT interval prolongation syndrome.
    Alves LE; Rose EP; Mueller HS
    Chest; 1982 Feb; 81(2):253-5. PubMed ID: 7056094
    [No Abstract]   [Full Text] [Related]  

  • 38. [Relationship between anti-arrhythmia effect and pharmacological data of Brufacaine in parenteral and oral administration in man].
    Burhorn D; Siegers CP; Diederich KW
    Verh Dtsch Ges Inn Med; 1975; 81():187-90. PubMed ID: 1229491
    [No Abstract]   [Full Text] [Related]  

  • 39. Ionic basis of pharmacological therapy in Brugada syndrome.
    Márquez MF; Salica G; Hermosillo AG; Pastelín G; Gómez-Flores J; Nava S; Cárdenas M
    J Cardiovasc Electrophysiol; 2007 Feb; 18(2):234-40. PubMed ID: 17338775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic toxicity and micronucleus assay of the new cardioprotective agent stobadine in rats.
    Gajdosiková A; Ujházy E; Gajdosik A; Chalupa I; Blasko M; Tomásková A; Liska J; Dubovicky M; Bauer V
    Arzneimittelforschung; 1995 May; 45(5):531-6. PubMed ID: 7612050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.